Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wilder

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 1, 1994
The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenograftsR B Wilder, J K McGann, W R Sutherland, et al.
Plos Neglected Tropical Diseases|November 21, 2025
Strengthening dermatology capacity and competency in resource-limited settings: A viewpointAnnika B Wilder-Smith, Jianing Li, L Claire Fuller, et al.
American Journal of Clinical Oncology|August 24, 2000
Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary resultsR B Wilder, R H Chou, J K Ryu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective studyChul S Ha, Joseph S Kong, Susan L Tucker, et al.
Seminars in Oncology|December 16, 2014
Altered fractionation schedules in radiation treatment: a reviewKamran A Ahmed, Candace R Correa, Thomas J Dilling, et al.
Practical Radiation Oncology|November 22, 2014
A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancerEric A Mellon, Khosrow Javedan, Tobin J Strom, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2001
Long-term results with radiotherapy for Stage I-II follicular lymphomasR B Wilder, D Jones, S L Tucker, et al.
International Journal of Radiation Oncology, Biology, Physics|November 10, 2000
Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomasP J Schlembach, R B Wilder, S L Tucker, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 27, 2014
Lipiodol as a fiducial marker for image-guided radiation therapy for bladder cancerJessica M Freilich, Philippe E Spiess, Matthew C Biagioli, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2002
Radiotherapy alone for lymphocyte-predominant Hodgkin's diseasePamela J Schlembach, Richard B Wilder, Dan Jones, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|January 1, 1994
The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenograftsR B Wilder, J K McGann, W R Sutherland, et al.
Plos Neglected Tropical Diseases|November 21, 2025
Strengthening dermatology capacity and competency in resource-limited settings: A viewpointAnnika B Wilder-Smith, Jianing Li, L Claire Fuller, et al.
American Journal of Clinical Oncology|August 24, 2000
Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary resultsR B Wilder, R H Chou, J K Ryu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective studyChul S Ha, Joseph S Kong, Susan L Tucker, et al.
Seminars in Oncology|December 16, 2014
Altered fractionation schedules in radiation treatment: a reviewKamran A Ahmed, Candace R Correa, Thomas J Dilling, et al.
Practical Radiation Oncology|November 22, 2014
A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancerEric A Mellon, Khosrow Javedan, Tobin J Strom, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2001
Long-term results with radiotherapy for Stage I-II follicular lymphomasR B Wilder, D Jones, S L Tucker, et al.
International Journal of Radiation Oncology, Biology, Physics|November 10, 2000
Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomasP J Schlembach, R B Wilder, S L Tucker, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 27, 2014
Lipiodol as a fiducial marker for image-guided radiation therapy for bladder cancerJessica M Freilich, Philippe E Spiess, Matthew C Biagioli, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2002
Radiotherapy alone for lymphocyte-predominant Hodgkin's diseasePamela J Schlembach, Richard B Wilder, Dan Jones, et al.
Pageof 11